Pexeva and Suicide
In clinical studies, there appeared to be a slightly increased risk of suicidal behavior in children and teenagers who took antidepressants such as Pexeva. However, it is difficult to tell for sure if there is a link between Pexeva and suicidal behavior. You should contact your child's doctor immediately if you notice any suicidal behaviors, such as aggressive behavior and acting on dangerous impulses.
Is There a Link Between Suicide and Pexeva?Pexeva® (paroxetine mesylate) is a prescription medication used for the treatment of the following conditions:
- Major depressive disorder (also known as major depression)
- Obsessive-compulsive disorder (OCD)
- Panic disorder
- Generalized anxiety disorder (GAD).
Pexeva belongs to a group of drugs called selective serotonin reuptake inhibitors (SSRIs). As with all antidepressants, there may be an increased risk of suicidal thoughts and behavior when taking Pexeva.
FDA Warning on Pexeva and Suicide
The U.S. Food and Drug Administration (FDA) has issued a special warning about the risk of suicidal thinking and behavior with antidepressant use in children, adolescents, and young adults aged 24 and younger. The warning was issued due to concerns that antidepressants seemed to increase the risk of suicidal thinking and behavior in people up to the age of 25 in clinical studies.
Although Pexeva is not approved for use in children or teenagers, it may be used "off-label" in this age group.